Grant Detail
The grant detail shows the name of the PI, active dates of the project, the funding institute and the abstract of the grant. This abstract is what is used to create the fingerprint of the grant. If any publications referencing this grant are found in the data, they will be listed here as well.
Synaptic Plasticity In Aging And Neurodegenerative Disorders
NATIONAL INSTITUTE ON AGING
Total Funding: $ 2,043,110
The ability of synapses to change their properties in response to environmental demands (synaptic plasticity) is essential for learning and memory. Abnormalities in synaptic plasticity are involved in Alzheimers disease and related disorders. In our continuing efforts to understand the molecular mechanisms involved in synaptic plasticity, in the contexts of aging and neurodegenerative disorders, we have made two major advances. 1) During development of the nervous system, the fate of stem cells is regulated by a cell surface receptor called Notch. Notch is also present in the adult mammalian brain;however, because Notch null mice die during embryonic development, it has proven difficult to determine the functions of Notch. Here, we used Notch antisense transgenic mice that develop and reproduce normally, but exhibit reduced levels of Notch, to demonstrate a role for Notch signaling in synaptic plasticity. Mice with reduced Notch levels exhibit impaired long-term potentiation (LTP) at hippocampal CA1 synapses. A Notch ligand enhances LTP in normal mice and corrects the defect in LTP in Notch antisense transgenic mice. Levels of basal and stimulation-induced NF-kappa B activity were significantly decreased in mice with reduced Notch levels. These findings suggest an important role for Notch signaling in a form of synaptic plasticity known to be associated with learning and memory processes. 2) Although ATP is reported to modulate synaptic plasticity, the mechanism of action of ATP on synaptic transmission is not fully understood. Here we show that ATP enhances long-term potentiation (LTP), and P2X receptor antagonists inhibit this ATP effect, but do not affect paired pulse facilitation (PPF) in rat hippocampal slices. ATP rapidly increases intracellular calcium, and P2X receptor antagonists inhibit this increase in cultured dissociated neurons. These results indicate that ATP enhances LTP via activation of postsynaptic P2X receptors. In additional studies, we have found that intermittent fasting and caloric restriction ameliorate age-related learning and memory deficits in a novel transgenic mouse model of Alzheimers disease. We also found that the antidepressant drug paroxetine was effective in suppressing amyloid pathology and preserving learning and memory ability in the same mouse model of Alzheimers disease. Other experiments have shown that diabetes impairs hippocampal neurogenesis and synaptic plasticity as the result of a chronic elevation in the level of adrenal glucocorticoids. We have found that perturbed membrane sphingolipid metabolism occurs in the brain in aging, Alzheimer's disease and HIV dementia. Studies of experimental models suggest that excessive activation of sphingomyelinases result in aberrant production of ceramides and perturbed membrane excitability and synaptic plasticity. More recently, we have discovered that several different toll-like receptors (TLRs) that were previously believed to be involved only in immune responses to infection, play important roles in synaptic plasticity and learning and memory. TLRs are therefore potential targets for the development of novel therapeutic interventions for cognitive impairment and Alzheimer's disease. Notch signaling in the nervous system has been most studied in the context of cell fate specification. However, numerous studies have suggested that Notch also regulates neuronal morphology, synaptic plasticity, learning, and memory. Here we show that Notch1 and its ligand Jagged1 are present at the synapse, and that Notch signaling in neurons occurs in response to synaptic activity. In addition, neuronal Notch signaling is positively regulated by Arc/Arg3.1, an activity-induced gene required for synaptic plasticity. In Arc/Arg3.1 mutant neurons, the proteolytic activation of Notch1 is disrupted both in vivo and in vitro. Conditional deletion of Notch1 in the postnatal hippocampus disrupted both long-term potentiation (LTP) and long-term depression (LTD), and led to deficits in learning and short-term memory. Our findings show that Notch signaling is dynamically regulated in response to neuronal activity, Arc/Arg3.1 is a context-dependent Notch regulator, and Notch1 is required for the synaptic plasticity that contributes to memory formation. Presenilin 1 (PS1) mutations are responsible for many early-onset familial Alzheimer's disease (FAD) cases. While increasing evidence points to impaired synaptic plasticity as an early event in AD, PS1 mutant mice exhibit a paradoxical increase in hippocampal long-term potentiation (LTP). Among PS1 mouse models, PS1 M146V mutant knock-in mice (PS1KI) are particularly interesting in that they exhibit memory impairment in spatial tasks. Here we investigated the effects of aging on two forms of LTP in PS1KI mice, the widely-studied early phase of LTP (E-LTP) and a particular form of LTP called late-LTP (L-LTP) which requires transcription and protein synthesis. L-LTP is thought to be critical for long-term memory. We found a lower L-LTP maintenance phase in PS1KI mice compared to wild type littermates at 3 months of age. As the mice age, they exhibit impairment of both the induction and maintenance phases of LTP. When E-LTP and NMDA receptor-mediated transmission were analyzed, PS1KI mice displayed an increase at 3 months compared to wild type littermates;this difference did not persist at older ages and finally decreased at 12 months. Our These results reveal an L-LTP decrease in PS1 mutant mice at an early stage, which occurs coincidently with a paradoxical enhancement of E-LTP. The observation of a decrease in both forms of LTP during aging supports the view that PS1KI mice are a valuable model for the study of age-dependent synaptic dysfunction and cognitive decline in AD. The synaptic insertion or removal of AMPA receptors (AMPAR) plays critical roles in the regulation of synaptic activity reflected in the expression of long-term potentiation (LTP) and long-term depression (LTD). The cellular events underlying this important process in learning and memory are still being revealed. Here we describe and characterize the AAA+ ATPase Thorase, which regulates the expression of surface AMPAR. In an ATPase-dependent manner Thorase mediates the internalization of AMPAR by disassembling the AMPAR-GRIP1 complex. Following genetic deletion of Thorase, the internalization of AMPAR is substantially reduced, leading to increased amplitudes of miniature excitatory postsynaptic currents, enhancement of LTP, and elimination of LTD. These molecular events are expressed as deficits in learning and memory in Thorase null mice. Thus, we have identified a novel an AAA+ ATPase that plays a critical role in regulating the surface expression of AMPAR and thereby regulates synaptic plasticity and learning and memory.
34 Resulting Publications
-
1.
2012Marc Gleichmann; Yongqing Zhang; William H Wood; Kevin G Becker; Mohamed R Mughal; Michael J Pazin; Henriette van Praag; Tali Kobilo; Alan B Zonderman; Juan C Troncoso; et al.
Neurobiology of aging 2012;33(1):205.e1-18. -
2.
2012Sarah J Texel; Simonetta Camandola; Bruce Ladenheim; Sarah M Rothman; Mohamed R Mughal; Erica L Unger; Jean Lud Cadet; Mark P Mattson
Journal of neurochemistry 2012;120(1):125-34. -
3.
2011Grace E Stutzmann; Mark P Mattson
Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease.
Pharmacological reviews 2011;63(3):700-27. -
4.
2011Simonetta Camandola; Mark P Mattson
Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease.
Biochimica et biophysica acta 2011;1813(5):965-73. -
5.
2011Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Toll-like receptor signaling in neural plasticity and disease.
Trends in neurosciences 2011;34(5):269-81. -
6.
2011Sarah J Texel; Mark P Mattson
Antioxidants & redox signaling 2011;14(8):1519-34. -
7.
2011Carola Romberg; Mark P Mattson; Mohamed R Mughal; Timothy J Bussey; Lisa M Saksida
Impaired attention in the 3xTgAD mouse model of Alzheimer's disease: rescue by donepezil (Aricept).
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(9):3500-7. -
8.
2011Jeong Seon Yoon; Jong-Hwan Lee; Tae Gen Son; Mohamed R Mughal; Nigel H Greig; Mark P Mattson
Pregabalin suppresses calcium-mediated proteolysis and improves stroke outcome.
Neurobiology of disease 2011;41(3):624-9. -
9.
2011Dimitrios Kapogiannis; Mark P Mattson
Lancet neurology 2011;10(2):187-98. -
10.
2010Xiangru Xu; Mohamed R Mughal; F Scott Hall; Maria T G Perona; Paul J Pistell; Justin D Lathia; Srinivasulu Chigurupati; Kevin G Becker; Bruce Ladenheim; Laura E Niklason; et al.
Journal of neurochemistry 2010;114(1):323-34. -
11.
2010Eric Norman; Roy G Cutler; Richard Flannery; Yue Wang; Mark P Mattson
Journal of neurochemistry 2010;114(2):430-9. -
12.
2010Eitan Okun; Kathleen J Griffioen; Tae Gen Son; Jong-Hwan Lee; Nicholas J Roberts; Mohamed R Mughal; Emmette Hutchison; Aiwu Cheng; Thiruma V Arumugam; Justin D Lathia; et al.
TLR2 activation inhibits embryonic neural progenitor cell proliferation.
Journal of neurochemistry 2010;114(2):462-74. -
13.
2010Dong-Gyu Jo; Thiruma V Arumugam; Ha-Na Woo; Jong-Sung Park; Sung-Chun Tang; Mohamed Mughal; Dong-Hoon Hyun; Jun-Hyung Park; Yun-Hyung Choi; A-Ryeong Gwon; et al.
Neurobiology of aging 2010;31(6):917-25. -
14.
2010Tinghuai Wu; Jane Tian; Roy G Cutler; Richard S Telljohann; David A Bernlohr; Mark P Mattson; James T Handa
Laboratory investigation; a journal of technical methods and pathology 2010;90(6):906-14. -
15.
2010Eitan Okun; Mark P Mattson; Thiruma V Arumugam
Involvement of Fc receptors in disorders of the central nervous system.
Neuromolecular medicine 2010;12(2):164-78. -
16.
2010K Conant; Y Wang; A Szklarczyk; A Dudak; M P Mattson; S T Lim
Neuroscience 2010;166(2):508-21. -
17.
2010Thiruma V Arumugam; Terry M Phillips; Aiwu Cheng; Christopher H Morrell; Mark P Mattson; Ruiqian Wan
Age and energy intake interact to modify cell stress pathways and stroke outcome.
Annals of neurology 2010;67(1):41-52. -
18.
2010Mark P Mattson
ER calcium and Alzheimer's disease: in a state of flux.
Science signaling 2010;3(114):pe10. -
19.
2010Dong Liu; Michael Pitta; Jong-Hwan Lee; Balmiki Ray; Debomoy K Lahiri; Katsutoshi Furukawa; Mohamed Mughal; Haiyang Jiang; Julissa Villarreal; Roy G Cutler; et al.
Journal of Alzheimer's disease : JAD 2010;22(2):443-57. -
20.
2009Mark P Mattson
Experimental gerontology 2009;44(10):625-33. -
21.
2009Fangbai Wu; Yasuji Matsuoka; Mark P Mattson; Pamela J Yao
The clathrin assembly protein AP180 regulates the generation of amyloid-beta peptide.
Biochemical and biophysical research communications 2009;385(2):247-50. -
22.
2009C B Lu; W Fu; X Xu; M P Mattson
Neuroscience 2009;161(2):403-12. -
23.
2009Marc Gleichmann; Leon P Collis; Peter J S Smith; Mark P Mattson
Journal of neurochemistry 2009;109(2):644-55. -
24.
2009Eitan Okun; Kathleen J Griffioen; Justin D Lathia; Sung-Chun Tang; Mark P Mattson; Thiruma V Arumugam
Toll-like receptors in neurodegeneration.
Brain research reviews 2009;59(2):278-92. -
25.
2009Daniel A Bruestle; Roy G Cutler; Richard S Telljohann; Mark P Mattson
Decline in daily running distance presages disease onset in a mouse model of ALS.
Neuromolecular medicine 2009;11(2):58-62. -
26.
2009R Varma; Y Chai; J Troncoso; J Gu; H Xing; S S Stojilkovic; M P Mattson; N J Haughey
Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity.
Neuromolecular medicine 2009;11(2):63-75. -
27.
2008Mark P Mattson; Marc Gleichmann; Aiwu Cheng
Mitochondria in neuroplasticity and neurological disorders.
Neuron 2008;60(5):748-66. -
28.
2008Mark P Mattson
Glutamate and neurotrophic factors in neuronal plasticity and disease.
Annals of the New York Academy of Sciences 2008;1144():97-112. -
29.
2008Peisu Zhang; Michael J Pazin; Catherine M Schwartz; Kevin G Becker; Robert P Wersto; Caroline M Dilley; Mark P Mattson
Current biology : CB 2008;18(19):1489-94. -
30.
2008Ittai Bushlin; Ronald S Petralia; Fangbai Wu; Asaff Harel; Mohamed R Mughal; Mark P Mattson; Pamela J Yao
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(41):10257-71. -
31.
2008Alexis M Stranahan; Kim Lee; Mark P Mattson
Ageing research reviews 2008;7(3):164-76. -
32.
2008Alexis M Stranahan; Eric D Norman; Kim Lee; Roy G Cutler; Richard S Telljohann; Josephine M Egan; Mark P Mattson
Hippocampus 2008;18(11):1085-8. -
33.
2007Rhonda L Nelson; Zhihong Guo; Veerendra Madala Halagappa; Michelle Pearson; Audrey J Gray; Yasuji Matsuoka; Martin Brown; Bronwen Martin; Titilola Iyun; Stuart Maudsley; et al.
Experimental neurology 2007;205(1):166-76. -
34.
2004
Scientific Context
This section shows information that has been computed by using the fingerprint of the grant, including related publications, related experts and related grants - all with fingerprints representing significant amounts of overlap between their fingerprint and this grant. The red dots indicate whether those experts or terms actually appear within this grant, showing potential and actual connections.
Related Grants
Related Publications
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications

